Announcement on Obtaining the Approval for Supplementary Application for Drugs for the Core Product Freeze-dried Rabies Vaccine (Vero Cells)

About this update from Liaoning Chengda Biotechnology Co. Ltd. Class A

Announcement on Obtaining the Approval for Supplementary Application for Drugs for the Core Product Freeze-dried Rabies Vaccine (Vero Cells) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Liaoning Chengda Biotechnology Co. Ltd. Class A